Marvisi, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 594
EU - Europa 435
AS - Asia 96
OC - Oceania 3
AF - Africa 2
SA - Sud America 1
Totale 1.131
Nazione #
US - Stati Uniti d'America 587
IT - Italia 256
SE - Svezia 65
HK - Hong Kong 54
DE - Germania 35
GB - Regno Unito 33
CN - Cina 26
FI - Finlandia 20
BG - Bulgaria 8
IE - Irlanda 6
FR - Francia 4
MX - Messico 4
CZ - Repubblica Ceca 3
JP - Giappone 3
TR - Turchia 3
UA - Ucraina 3
AU - Australia 2
CA - Canada 2
ID - Indonesia 2
IL - Israele 2
IN - India 2
KR - Corea 2
MA - Marocco 2
BR - Brasile 1
BZ - Belize 1
GR - Grecia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
Totale 1.131
Città #
Chandler 91
Fairfield 69
Ashburn 66
Nyköping 56
Hong Kong 54
Seattle 25
Houston 23
Cambridge 22
Woodbridge 22
Bologna 21
Helsinki 20
San Diego 20
Wilmington 20
Milan 18
New York 18
Rome 15
Bremen 13
Princeton 13
Shanghai 12
Des Moines 8
London 8
Modena 8
Sofia 8
Beijing 7
Florence 7
Reggio Emilia 7
Ann Arbor 6
Dearborn 6
Dublin 6
Padova 6
Trieste 6
Cremona 5
Falls Church 5
Southend 5
Treviso 5
Udine 5
Brindisi 4
Council Bluffs 4
Credaro 4
Huskvarna 4
Monza 4
Munich 4
Roccapalumba 4
Atlanta 3
Bari 3
Boardman 3
Brno 3
Chicago 3
Genoa 3
Hounslow 3
Parma 3
Ponte dell'Olio 3
Prescot 3
Redwood City 3
Reston 3
Andover 2
Ankara 2
Bacoli 2
Basildon 2
Benevento 2
Bolzano 2
Cagliari 2
Casablanca 2
Cecina 2
Cuauhtemoc 2
Dalmine 2
Desio 2
Eugene 2
Gragnano 2
Ischia 2
Jacksonville 2
Jakarta 2
Kilburn 2
Lucca 2
Maerne 2
Mantova 2
Modica 2
Palermo 2
Palma Campania 2
Pescara 2
Pieve Emanuele 2
Pontedera 2
Ramat Gan 2
Rende 2
Romainville 2
San Marco Evangelista 2
Saronno 2
Seo-gu 2
Tarquinia 2
Terranuova Bracciolini 2
Tijuana 2
Tirano 2
Utsunomiya 2
Verona 2
Wandsworth 2
Acton 1
Adria 1
Albuquerque 1
Auckland 1
Baltimore 1
Totale 855
Nome #
VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis 155
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 115
EULAR guidelines on ANCA-associated vasculitis in the real life 108
New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group 106
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 91
Chronic periaortitis presenting with isolated pulmonary artery involvement: description of two cases 69
Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference Center 59
Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 57
Tofacitinib for the treatment of refractory Takayasu's arteritis: description of 2 cases 52
Vessel inflammation and morphological changes in patients with large vessel vasculitis: A retrospective study 50
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features 46
The management of large vessel vasculitides 45
EVALUATION OF INTERNAL CONSISTENCY, FEASIBILITY, AND RELIABILITY OF THE ITALIAN VERSION OF ANCA-ASSOCIATED VASCULITIS PATIENT-REPORTED OUTCOME (AAV-PRO_ITA) QUESTIONNAIRE: PRELIMINARY RESULTS FROM A MULTICENTER STUDY ON A LARGE COHORT OF ITALIAN PATIENTS 38
Vasculitis, fibromuscular dysplasia or hereditary aneurysms? 37
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 26
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis 21
Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases 20
EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 14
PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG-STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 13
354. EFFICACY OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS TREATMENTS ACCORDING TO THE TYPE OF MANIFESTATIONS BASED ON ANALYSIS OF 636 PATIENTS 12
117. PREDICTION OF LONG-TERM EVOLUTIONARY PROFILES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (CHURG– STRAUSS) BASED ON BASELINE AND FOLLOW-UP CHARACTERISTICS 10
Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study 5
Steroid-sparing agents in polymyalgia rheumatica: how will they fit into the treatment paradigm? 5
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: A matched cross-sectional study 4
Reply 3
The Role of PET in the Diagnosis and Disease Activity Assessment in Large Vessel Vasculitis 3
Pros and cons of TNF inhibitors and tocilizumab in the treatment of large-vessel vasculitis 2
Reply to Comment on: Vasculitis, fibromuscular dysplasia or hereditary aneurysms? by Marvisi et al 1
Totale 1.167
Categoria #
all - tutte 9.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 0 0 0 3 5 8 5 9 8 1 4 1
2020/2021105 4 3 2 6 36 6 9 3 8 5 7 16
2021/2022224 2 23 16 7 10 17 9 13 20 14 45 48
2022/2023443 33 47 23 18 63 44 32 47 51 22 37 26
2023/2024351 13 23 13 59 46 51 55 44 16 31 0 0
Totale 1.167